Magnetic Resonance - Technology Information Portal Welcome to MRI Technology
Info
  Sheets

Out-
      side
 

Next big thing in MRI will be :
AI 
remote operator 
personalized protocols 
helium-free 
molecular MRI 
portable MRI 




 
MRI News Service:
'Gadolinium'  p8
SEARCH NEWS FOR   
 
Result: Searchterm 'Gadolinium' found in 77 news
Result Pages
...
More Results: Database  (66)  Resources  (6)  Forum  (17)  
News     News Refinements:  Contrast Agents  Devices  Financial  
Important Drug Warning for Gadolinium-Based Contrast Agents
''The manufacturers of gadolinium-based contrast agents would like to inform you of important revisions to the prescribing information for the products listed in alphabetical order above. Gadolinium-based contrast agents are approved by the U.S. Food ...'
Wednesday, 12 September 2007   by www.ismrm.org
Pharmacyclics Announces Positive Final Results of Phase 2 Trial of Xcytrin(R) Plus Radiosurgery for Brain Metastases With Occult Tumors Detected in 24% of Patients
''CHICAGO and SUNNYVALE, Calif., June 3 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today announced final results from an open-label multi-center Phase 2 clinical trial, which indicated that Xcytrin(R) (motexafin gadolinium) ...'
Sunday, 3 June 2007   by www.prnewswire.com
Gadograf, Gadovist
''Gadovist/Gadograf 1.0 mmol/ml contains gadobutrol, a neutral macrocyclic gadolinium (Gd) complex with contrast-enhancing properties, which is used for magnetic resonance imaging (MRI). MRI is a widely used technique for the evaluation and detection of ...'
Friday, 13 April 2007   by www.ema.europa.eu
Gadolinium-based MR Contrast Agents and Nephrogenic Systemic Fibrosis
''Nephrogenic systemic fibrosis (NSF), described in 2000 (1), is an emerging systemic disorder characterized by widespread tissue fibrosis. Originally known as nephrogenic fibrosing dermopathy because of its dominant cutaneous findings, the nomenclature ...'
Thursday, 1 March 2007   by radiology.rsna.org
Pharmacyclics Announces Results from Phase 3 Smart Trial of Xcytrin(R) for Lung Cancer Brain Metastases
''SUNNYVALE, Calif., Dec 19, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today announced top-line results from its pivotal Phase 3 clinical study of Xcytrin(R) (motexafin gadolinium) Injection, for the ...'
Monday, 19 December 2005   by www.prnewswire.com
'Gadonanotubes' greatly outperform existing MRI contrast agents
''Placing gadolinium in DNA-sized carbon tubes boosts performance, reduces toxicity HOUSTON, Aug. 11, 2005 -- Researchers at Rice University, the Baylor College of Medicine, the University of Houston and the Ecole Polytechnique Fédérale de Lausanne in ...'
Thursday, 11 August 2005   by www.eurekalert.org
DNA-SEEKING GADOLINIUM COMPLEXES FOR NEUTRON CAPTURE THERAPY (NCT) (.pdf)
News     News Refinements:  Contrast Agents  Devices  Financial  
Radiology News Open this link in a new window Ultrasound Imaging News Open this link in a new window
Result Pages
...
Anybody can sympathise with the sufferings of a friend, but it requires a very fine nature to sympathise with a friend's success.
- Oscar Wilde
 
Share This Page
FacebookTwitterLinkedIn

MR-TIP    
Community   
User
Pass
Forgot your UserID/Password ?    



Look
      Ups





MR-TIP.com uses cookies! By browsing MR-TIP.com, you agree to our use of cookies.

Magnetic Resonance - Technology Information Portal
Member of SoftWays' Medical Imaging Group - MR-TIP • Radiology-TIP • Medical-Ultrasound-Imaging • 
Copyright © 2003 - 2025 SoftWays. All rights reserved. [ 20 May 2025]
Terms of Use | Privacy Policy | Advertising
 [last update: 2025-05-13 01:28:00]